ANIK Anika Therapeutics Inc.

Anika to Participate in Upcoming Virtual Investor Conferences

Anika to Participate in Upcoming Virtual Investor Conferences

BEDFORD, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care, today announced that Cheryl R. Blanchard, Ph.D., President and Chief Executive Officer, and Michael Levitz, Chief Financial Officer, will participate in the following four virtual investor conferences in September:

  • Barrington Research Fall Investment Conference on Wednesday, September 9, 2020. Dr. Blanchard and Mr. Levitz will participate in virtual one-on-one meetings with investors.
  • Wells Fargo Healthcare Conference on Thursday, September 10, 2020. Dr. Blanchard is scheduled to participate in a fireside chat at 10:40 a.m. ET.
  • Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2020. Dr. Blanchard is scheduled to participate in a fireside chat at 8:45 a.m. ET.
  • Sidoti Investor Conference on Thursday, September 24, 2020. Dr. Blanchard is scheduled to present at 9:15 a.m. ET.

Live audio webcasts of the Wells Fargo, Morgan Stanley and Sidoti presentations may be accessed via the section of Anika’s website, . Audio archives of the presentations also will be available on the website.

About Anika Therapeutics, Inc.



(NASDAQ: ANIK), is a global, integrated joint preservation, restoration and regenerative solutions company based in Bedford, Massachusetts. Anika is committed to delivering products along the orthopedic early intervention continuum of care to improve the lives of patients, with a focus on osteoarthritis pain management, sports medicine and joint preservation, restoration and regeneration. The Company has close to three decades of global expertise commercializing innovative products across the orthopedic early intervention continuum of care For more information about Anika, please visit .

For Investor Inquiries:

Anika Therapeutics, Inc.

Kristen Galfetti, 781-457-9000

Executive Director, Investor Relations



For Media Inquiries:

W2O Group

Rachel Girard, 617-379-6760  

 

EN
03/09/2020

Underlying

ANIKAnika Therapeutics Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Anika Therapeutics Inc.

 PRESS RELEASE
Free
ANIK Anika Therapeut...

Anika Reports Third Quarter 2025 Financial Results

Anika Reports Third Quarter 2025 Financial Results Commercial Channel revenue up 22% with continued strong Integrity™ Implant System and Hyalofast® growth, and double-digit International OA Pain Management growth Third and final Hyalofast PMA module filed and data released Cingal® achieved commercial milestone of more than one million injections worldwide since 2016 Reaffirming Fiscal 2025 guidance and long-term outlook and commencing a $15 million 10b5-1 share repurchase BEDFORD, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (Nasdaq: ANIK), a global leader in the ...

November 5, 2025 1 EN
 PRESS RELEASE
Free
ANIK Anika Therapeut...

Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® C...

Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study BEDFORD, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in joint preservation and regenerative solutions, announced that it filed the third and final module of its Premarket Approval application (PMA) for Hyalofast—its resorbable, hyaluronic acid-based scaffold used with autologous bone marrow aspirate concentrate (BMAC) for treating articular cartilage defects in the knee. The Company also re...

November 5, 2025 1 EN
 PRESS RELEASE
Free
ANIK Anika Therapeut...

Anika to Issue Third Quarter 2025 Financial Results on Wednesday, Nove...

Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 BEDFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2025 financial results before the opening of the market on Wednesday, November 5, 2025, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights. The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the con...

October 23, 2025 1 EN
 PRESS RELEASE
Free
ANIK Anika Therapeut...

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BEDFORD, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on September 2, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 2,500 shares of common stock at a per share exercise price of $9.15, which equaled the closing price of common stock on the Nasdaq Global Select Market on the grant date, to one newly hired non-executive e...

September 5, 2025 1 EN
 PRESS RELEASE
Free
ANIK Anika Therapeut...

Anika Reports Second Quarter 2025 Financial Results

Anika Reports Second Quarter 2025 Financial Results Regenerative Solutions revenue up 41% with Integrity™ Implant System ahead of expectations and continued strong Hyalofast® growth; Integrity surpasses full year 2024 performance and is on pace to more than double in 2025 Company released topline results for Hyalofast® clinical trial which did not meet pre-specified co-primary end points; Hyalofast demonstrated statistically significant improvements in pre-defined secondary endpoints and other measures; Company plans to file the final PMA module in second half 2025 Reaffirming Fis...

July 30, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch